FDA Drug Application (202016) for MELAMISA by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number202016
Product Number001
FormTABLET;ORAL
Dosage3MG;0.02MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMELAMISA
Active IngredientDROSPIRENONE; ETHINYL ESTRADIOL

Active IngredientCount
List of drugs with Active Ingredient DROSPIRENONE12
List of drugs with Active Ingredient ETHINYL ESTRADIOL226


Back to FDA Applications sponsored by NOVAST LABS LTD